Open Call: Apply for TRANSVAC2 Vaccine Development Services

Open Call: Apply for TRANSVAC2 Vaccine Development Services Developing a vaccine is a time-consuming and complex process, requiring a combination of specialized skills and technical capacities not readily available at...

FIND and BIOASTER collaborate on clinical research

FIND and BIOASTER collaborate on clinical research to assess duration of immune response in patients with COVID-19 Studies will assess whether there is an association between detection of COVID-19 antibodies...

Pre-print publication COVID19

PRE-PRINT COVID19: Discovery of clinically approved drugs capable of inhibiting SARS-CoV-2 in vitro infection using a phenotypic screening strategy and network-analysis to predict their potential to treat covid-19 Authors: Douglas...

BIOASTER & GENCOVERY

BIOASTER first shareholder with its two co-founders Adama OUATTARA and Wassim ABOU-JAOUDE of Gencovery. Wishing success to the first BIOASTER start-up. Gencovery provides cutting-edge software based on digital organisms for...

Discover our new @BIOASTER publication in Poultry Sciences

Discover our new @BIOASTER publication in @PoultrySci We are really happy to share our new publication in @PoultrySci. This #Multiomics study, combining #Metabolomics and #Transcriptomics, aims at deciphering the pathways...
Post archive